GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CareCloud Inc (NAS:CCLD) » Definitions » GF Value

CCLD (CareCloud) GF Value : $2.42 (As of Mar. 14, 2025)


View and export this data going back to 2014. Start your Free Trial

What is CareCloud GF Value?

As of today (2025-03-14), CareCloud's share price is $1.475. CareCloud's GF Value is $2.42. Therefore, CareCloud's Price-to-GF-Value for today is 0.61. Based on the relationship between the current stock price and the GF Value, GuruFocus believes CareCloud is Possible Value Trap, Think Twice.

The GF Value represents the intrinsic value of a stock, determined using GuruFocus' proprietary methodology. The GF Value Line on our stock Summary page provides an estimate of the stock’s fair-trading value.

To calculate this value, GuruFocus follows these steps:

  1. We analyze historical correlations between the stock price and key business performance metrics, such as revenue, earnings, cash flow, and book value.
  2. We identify the metrics that have the strongest historical correlation with the stock price and determine the historical multiples at which the stock has traded relative to these metrics.
  3. Using these historical multiples as a reference, we estimate the stock's fair value while accounting for future business growth. Adjustments may be made based on the company’s past returns and growth trends.

GuruFocus believes that the GF Value Line represents the fair value at which a stock should trade. Stock prices typically fluctuate around this line. If a stock’s price is significantly above the GF Value Line, it is considered overvalued, and its future returns are likely to be lower. Conversely, if the stock price is significantly below the GF Value Line, its future returns are likely to be higher.

Please note that "Possible Value Trap, Think Twice" applies to companies that appear significantly undervalued but are either experiencing a long-term business decline or facing financial distress.


CareCloud  (NAS:CCLD) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 ratings:

Posssible Evaluations All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)Predictable Companies that possibly be Value Traps
Significantly OvervaluedPredictable Companies which are Significantly Overvalued
Modestly OvervaluedPredictable Companies which are Modestly Overvalued
Fairly ValuedPredictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" applies to companies that appear significantly undervalued but are either experiencing a long-term business decline or facing financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) A sufficient margin of safety exists only when the stock is undervalued.

CareCloud's Price-to-GF-Value for today is calculated as

Price-to-GF-Value=Share Price/GF Value
=1.475/2.42
=0.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CareCloud GF Value Related Terms

Thank you for viewing the detailed overview of CareCloud's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.


CareCloud Business Description

Traded in Other Exchanges
Address
7 Clyde Road, Somerset, NJ, USA, 08873
CareCloud Inc is a healthcare information technology company. It provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, telehealth, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue generating segment, and Practice Management.
Executives
John N Daly director 390 STANWICH ROAD, GREENWICH CT 06830
Cameron Munter director 295 WEST ORANGE GROVE AVE, SIERRA MADRE CA 91024
Mahmud Ul Haq director, 10 percent owner, officer: Chief Executive Officer 7 CLYDE ROAD, SOMERSET NJ 08873
Lawrence Steven Sharnak director 7393, ORANGEWOOD LANE, BOCA RATON FL 33433
Anne Busquet director 390 PARK AVE 4TH FLR, NEW YORK NY 10022
A Hadi Chaudhry officer: President 7 CLYDE ROAD, SOMERSET NJ 08873
Nathalie Grey Garcia officer: General Counsel & Secretary 7 CLYDE ROAD, SOMERSET NJ 08873
Lawrence J. Steenvoorden officer: Chief Financial Officer C/O CHEMBIO DIAGNOSTICS, INC., 555 WIRELESS BOULEVARD, HAUPPAUGE NY 11788
Stephen Andrew Snyder director, officer: President 7 CLYDE ROAD, SOMERSET NJ 08873
Bill Korn officer: Chief Financial Officer 61 DARREN DRIVE, BASKING RIDGE NJ 07920
Kimberly J Grant officer: General Counsel & Secretary 7 CLYDE ROAD, SOMERSET NJ 08873
Shruti H Patel officer: Interim Corporate Secretary 7 CLYDE ROAD, SOMERSET NJ 08873
Amritpal K. Deol officer: See Remarks 7 CLYDE ROAD, SOMERSET NJ 08873
Norman Roth officer: See Remarks 7 CLYDE ROAD, SOMERSET NJ 08873
Brendan Patrick Harney officer: See Remarks 7 CLYDE ROAD, SOMERSET NJ 08873